Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,295 | -14,962 | -7,543 | -4,267 | -18,600 |
| Depreciation Amortization | 1,311 | 976 | 643 | 332 | 1,340 |
| Accounts receivable | -39 | -51 | -2 | -973 | 45 |
| Other Working Capital | 1,470 | -1,563 | -1,867 | -973 | 1,220 |
| Other Operating Activity | 1,840 | 1,147 | -1,496 | 661 | -1,765 |
| Operating Cash Flow | $-18,713 | $-14,453 | $-10,265 | $-5,220 | $-17,760 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,119 | 6,950 | 6,998 | 2,957 | 27 |
| PPE Investments | 31,110 | 5 | -4 | -1 | -6 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -41 |
| Investing Cash Flow | $9,991 | $6,955 | $6,994 | $2,956 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,833 | 14,075 | 6,640 | N/A | 839 |
| Other Financing Activity | 32,782 | 0 | 0 | 0 | -9 |
| Financing Cash Flow | $42,615 | $14,075 | $6,640 | $N/A | $830 |
| Beginning Cash Position | 5,756 | 5,756 | 5,756 | 5,756 | 22,700 |
| End Cash Position | 39,649 | 12,333 | 9,125 | 3,492 | 5,750 |
| Net Cash Flow | $33,893 | $6,577 | $3,369 | $-2,264 | $-16,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,713 | -14,453 | -10,265 | -5,220 | -17,760 |
| Capital Expenditure | -25 | -8 | -4 | -1 | -50 |
| Free Cash Flow | -18,738 | -14,461 | -10,269 | -5,221 | -17,810 |